Comparative Efficacy of Gingko biloba and Ashwagandha with Caroverine in the Treatment of Idiopathic Tinnitus: An Investigative Clinical Study

Authors

  • Meenakshi Srinivasan
  • Raadhika Shree. N

Keywords:

Idiopathic tinnitus, Gingko biloba, Ashwagandha, Caroverine, Tinnitus Handicap Inventory

Abstract

Idiopathic tinnitus, a condition characterized by the perception of sound without external stimuli, significantly affects quality of life, causing distress, anxiety, and sleep disturbances. Current treatments show inconsistent efficacy due to the multifactorial nature of tinnitus, leading to interest in alternative therapies. This randomized controlled trial aimed to compare the efficacy of Gingko biloba and Ashwagandha combined with Caroverine in managing idiopathic tinnitus. Fifty patients were divided into two groups: Group 1 received Gingko biloba (60 mg/day) with Caroverine (20 mg/day), and Group 2 received Ashwagandha (300 mg twice daily) with Caroverine (20 mg/day). Outcomes were assessed using the Tinnitus Handicap Inventory (THI) at baseline, one month, three months, and six months post-treatment. Both groups demonstrated significant reductions in THI scores (p < 0.05) over six months, with improvements in tinnitus severity and its impact on daily life. While both treatments were effective, Ashwagandha offered comparable results to Gingko biloba, positioning it as a cost-effective alternative. These findings support the combined use of herbal supplements and Caroverine for managing tinnitus, providing new insights into complementary therapies for this challenging condition. Further studies are needed to explore long-term effects and psychological benefits in diverse populations

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Chen, Qian, Han Lv, Zhaodi Wang, Xuan Wei, Pengfei Zhao, Zhenghan Yang, Shusheng Gong, and Zhenchang Wang. 2021. “Outcomes at 6 Months Are Related to Brain Structural and White Matter Microstructural Reorganization in Idiopathic Tinnitus Patients Treated with Sound Therapy.” Human Brain Mapping 42 (3): 753–65.

Dadgarnia, Mohammadhossein, Mohammad Mandegari, Vahid Zand, Sedighe Vaziribozorg, Hadi Zare-Zardini, Kimia Mousaviyazdi, and Mohammadali Kheradmandi. 2024. “The Effect of Vitamin B12 on Idiopathic Tinnitus.” American Journal of Otolaryngology 45 (1): 104028.

Liu, Chunli, Jie Zhang, Zhiwei Qi, Wenhui Yue, Yujie Yuan, Tao Jiang, Shenglin Zhang, and Shujun Zhang. 2024. “Therapy Effect of Cochleural Alternating Acoustic Beam Therapy versus Traditional Sound Therapy for Managing Chronic Idiopathic Tinnitus Patients.” Scientific Reports 14 (1): 5900.

Xie, Liming, Qi Zhu, and Jiahong Lu. 2022. “Can We Use Ginkgo Biloba Extract to Treat Alzheimer’s Disease? Lessons from Preclinical and Clinical Studies.” Cells 11 (3): 479.

Kim, Hantai, Jungho Ha, Hun Yi Park, Yun-Hoon Choung, and Jeong Hun Jang. 2023. “Efficacy and Safety of Co-Administered St. John’s Wort and Extracts in Patients with Subjective Tinnitus: A Preliminary Prospective Randomized Controlled Trial.” Journal of Clinical Medicine Research 12 (9). https://doi.org/10.3390/jcm12093261.

Guo, Ying, Mingjiang Mao, Qiuying Li, Xiahui Yu, and Liping Zhou. 2022. “Extracts of Ginkgo Flavonoids and Ginkgolides Improve Cerebral Ischaemia-Reperfusion Injury through the PI3K/Akt/Nrf2 Signalling Pathway and Multicomponent in Vivo Processes.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 99 (May):154028.

Zahiruddin, Sultan, Parakh Basist, Abida Parveen, Rabea Parveen, Washim Khan, Gaurav, and Sayeed Ahmad. 2020. “Ashwagandha in Brain Disorders: A Review of Recent Developments.” Journal of Ethnopharmacology 257 (July):112876.

Hosny, Eman N., Mayada M. El-Gizawy, Hussein G. Sawie, Khaled G. Abdel-Wahhab, and Yasser A. Khadrawy. 2021. “Neuroprotective Effect of Ashwagandha Extract against the Neurochemical Changes Induced in Rat Model of Hypothyroidism.” Journal of Dietary Supplements 18 (1): 72–91.

Speers, Alex B., Kadine A. Cabey, Amala Soumyanath, and Kirsten M. Wright. 2021. “Effects of (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia.” Current Neuropharmacology 19 (9): 1468–95.

Farrah, Amira Yousry, Abdulaziz M. Al-Mahallawi, Emad B. Basalious, and Demiana I. Nesseem. 2020. “Investigating the Potential of Phosphatidylcholine-Based Nano-Sized Carriers in Boosting the Oto-Topical Delivery of Caroverine: In Vitro Characterization, Stability Assessment and Ex Vivo Transport Studies.” International Journal of Nanomedicine 15 (November):8921–31.

Basista, Hitender, Rohit Saxena, Vivek Kumar Pathak, and Sanjeev Awasthi. 2024. “A Comparative Analysis of the Efficacy of Ginkgo Biloba and Caroverine in the Management of Idiopathic Tinnitus.” Indian Journal of Otolaryngology and Head and Neck Surgery: Official Publication of the Association of Otolaryngologists of India 76 (5): 4386–92.

Kundal, Pankaj, Anupam Goswami, Kapil Mehar, Nancy Aggarwal, and Manjusha Rajagopala. 2024. “Management of Subjective Tinnitus with Conductive Hearing Loss through Ayurveda: An Experience.” Journal of Ayurveda Case Reports 7 (3): 148–52.

Downloads

Published

2025-05-26

How to Cite

1.
Srinivasan M, Shree. N R. Comparative Efficacy of Gingko biloba and Ashwagandha with Caroverine in the Treatment of Idiopathic Tinnitus: An Investigative Clinical Study. J Neonatal Surg [Internet]. 2025May26 [cited 2025Sep.10];14(25S):1033-9. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/6512